It is not clear from either human or experimental animal studies whether this primary hyperinsulinemia of pregnancy is beneficial (e.g. as a growth factor for fetal development or to provide necessary capacity to meet the insulin resistance of later pregnancy) or detrimental in term of, as noted above, β-cell health and insulin action later in pregnancy. The gene discussed is INS; the disease is Insulin resistance.